HYDERABAD, India, March 16, 2026 /PRNewswire/ -- According to Mordor Intelligence, the global prefilled syringes market is experiencing strong expansion as healthcare systems increasingly prioritize safe, convenient, and accurate drug delivery methods. The prefilled syringes market size is projected to grow from USD 9.74 billion in 2025 to USD 10.77 billion in 2026 and is expected to reach USD 18.12 billion by 2031, registering a CAGR of 10.96% during the 2026-2031 forecast period, supported by the rising adoption of biologic therapies, increasing prevalence of chronic diseases, and growing demand for self-administration devices across homecare settings.
Industry growth is strongly linked to the increasing global burden of chronic diseases such as diabetes, autoimmune disorders, and cardiovascular conditions. As treatment protocols increasingly rely on injectable therapies, healthcare providers are adopting prefilled syringes to improve dosing accuracy and patient adherence. Additionally, the expansion of vaccination programs and large-scale immunization initiatives continues to drive demand for reliable and easy-to-use injection systems. Advancements in syringe materials and manufacturing technologies are also contributing to market growth. The introduction of safety mechanisms, needle shielding systems, and polymer-based syringe designs is improving usability and reducing the risk of needlestick injuries. These innovations are encouraging broader adoption across hospitals, specialty clinics, and homecare environments.
Prefilled Syringes Market Share by Region
North America holds a significant share of the prefilled syringes market due to strong pharmaceutical manufacturing capabilities, widespread adoption of injectable biologics, and well-established healthcare infrastructure.
Europe represents another important regional market, supported by expanding vaccination programs, increasing adoption of advanced drug delivery systems, and growing investments in pharmaceutical innovation.
Asia-Pacific is emerging as a rapidly growing region due to rising healthcare expenditure, expanding pharmaceutical production capacity, and increasing demand for injectable therapies across large patient populations.
Other regions including the Middle East, Africa, and South America are also witnessing gradual adoption of prefilled syringe technologies as healthcare systems strengthen drug delivery infrastructure and improve access to modern treatments.
Prefilled Syringes Market Trends & Forecast
Rising Demand for Biologic Drug Delivery
The increasing use of biologic therapies for chronic disease management is accelerating the adoption of prefilled syringe drug delivery systems.
Growth of Self-Administration and Homecare Treatments
Prefilled syringes are gaining popularity due to their convenience, enabling patients to safely administer medications outside hospital settings.
Advancements in Safety and Needle Protection Technologies
Innovations in safety mechanisms and syringe design are improving patient safety while reducing the risk of accidental needlestick injuries.
Soumya Goud, Senior Research Manager, Mordor Intelligence, says, "The prefilled syringes market is advancing as healthcare systems prioritize safer delivery and dosing. Mordor Intelligence anchors its analysis in validated datasets and disciplined research review, providing executives a dependable reference against loosely documented market estimates."
Prefilled Syringes Market Segmentation Overview
By Material
- Glass Prefilled Syringes
- Polymer Prefilled Syringes
By Application
- Diabetes
- Rheumatoid Arthritis
- Vaccines
- Anticoagulants
- Other Applications
By End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Home Healthcare Settings
- Other End Users
By Geography
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
- South America
- Brazil
- Argentina
- Rest of South America
For a full breakdown of market dynamics, segmentation insights, regional analysis, and competitive landscape, access the details of the Mordor Intelligence report:https://www.mordorintelligence.com/industry-reports/prefilled-syringes-market?utm_source=prnewswire
Prefilled Syringes Market Competitive Outlook
The prefilled syringes market includes global pharmaceutical packaging manufacturers and medical device companies focusing on product innovation, strategic partnerships, and manufacturing expansion. Companies are investing in advanced materials, safety features, and compatibility with biologic drugs to strengthen their product portfolios and address the growing demand for safe and efficient injectable drug delivery systems.
Prefilled Syringes Companies include:
- Becton, Dickinson and Company
- Gerresheimer AG
- Schott AG
- West Pharmaceutical Services, Inc.
- Terumo Corporation
- Nipro Corporation
- Stevanato Group
- Vetter Pharma International GmbH
- Baxter International Inc.
- Medtronic plc
Industry Related Reports by Mordor Intelligence
Laboratory Supplies Market - The laboratory supplies market is estimated at USD 52.59 billion in 2026 and is projected to reach USD 75.93 billion by 2031, registering a CAGR of 7.62% during the forecast period. Growth is driven by increasing research activities in life sciences, rising demand for diagnostic testing, and expanding laboratory infrastructure across healthcare and academic institutions.
Subcutaneous Drug Delivery Devices Market - The subcutaneous drug delivery devices market is estimated at USD 36.74 billion in 2026 and is expected to reach USD 54.5 billion by 2031, growing at a CAGR of 8.20%. Market expansion is supported by increasing demand for self-administration devices, rising prevalence of chronic diseases, and growing adoption of biologics requiring subcutaneous delivery.
Dental Impression Materials Market - The dental impression materials market is estimated at USD 1.05 billion in 2026 and is projected to reach USD 1.59 billion by 2031, advancing at a CAGR of 8.63% during the forecast period. Growth is driven by increasing dental procedures, rising demand for restorative and prosthetic treatments, and expanding adoption of advanced dental materials in clinical practice.
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/contact-us
Logo: https://mma.prnewswire.com/media/2746908/Mordor_Intelligence_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/prefilled-syringes-market-to-surpass-usd-18-bn-by-2031-as-biologics-and-self-injection-devices-drive-adoption-says-mordor-intelligence-302714377.html
